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Abstract The actin cytoskeleton plays a central role in many
cell biological processes. The structure and dynamics of the actin
cytoskeleton are regulated by numerous actin-binding proteins
that usually contain one of the few known actin-binding motifs.
WH2 domain (WASP homology domain-2) is a V35 residue
actin monomer-binding motif, that is found in many different
regulators of the actin cytoskeleton, including the L-thymosins,
ciboulot, WASP (Wiskott Aldrich syndrome protein), verprolin/
WIP (WASP-interacting protein), Srv2/CAP (adenylyl cyclase-
associated protein) and several uncharacterized proteins. The
most highly conserved residues in the WH2 domain are important
in L-thymosin’s interactions with actin monomers, suggesting
that all WH2 domains may interact with actin monomers
through similar interfaces. Our sequence database searches did
not reveal any WH2 domain-containing proteins in plants.
However, we found three classes of these proteins: WASP, Srv2/
CAP and verprolin/WIP in yeast and animals. This suggests
that the WH2 domain is an ancient actin monomer-binding motif
that existed before the divergence of fungal and animal
lineages. ß 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Actin is a major constituent of the cytoskeleton in all eu-
karyotic cells. It exists both in a monomeric form (G-actin)
and in polar ¢lamentous structures (F-actin). The actin mono-
mer is always bound to a nucleotide, either ATP or ADP, and
the nucleotide status signi¢cantly a¡ects its biochemical prop-
erties. In most cells, the actin cytoskeleton is highly dynamic
and rapid actin ¢lament assembly and disassembly (i.e. turn-
over) are required for many cellular processes, such as endo-
cytosis, motility, division and morphogenesis. The dynamic
nature of actin ¢laments enables cells to respond quickly to
extracellular signals [1].
The rapid turnover is accomplished by a plethora of actin-
binding proteins. Many of these proteins interact with actin
through one of the following actin-binding motifs : the calpo-
nin homology domain [2,3], the ADF-H domain [4], the gel-
solin homology domain [5] or the thymosin L4/WH2 (WASP
homology domain-2) domain [6,7]. The calponin homology
domain appears to interact only with ¢lamentous actin, while
the ADF-H and the gelsolin homology domains are able to
bind both monomeric and ¢lamentous actin.
The WH2 domain is a small (approximately 35 amino
acids) motif found in a number of di¡erent proteins. All avail-
able biochemical data indicate that the WH2 domains bind to
actin monomers. Using BLAST and SMART searches, we
identi¢ed WH2 domains in a total of 37 proteins from Caeno-
rhabditis elegans, Drosophila melanogaster, Saccharomyces ce-
revisiae and Homo sapiens sequence databases. The molecular
weights of these proteins range from 5 kDa to 150 kDa, and
they contain from one to four copies of the domain per pro-
tein. Yeast has three WH2 domain-containing proteins where-
as humans have 18 di¡erent WH2 domain-containing pro-
teins. Interestingly, we did not identify any WH2 domain
proteins from plants in our database searches. The WH2 do-
main was recently reported in a group of minor baculoviral
capsid proteins, and it was suggested that these WH2 domain-
containing proteins may regulate actin dynamics during the
infection process [7]. Furthermore, WH2 domain-like sequen-
ces have been identi¢ed in Listeria monocytogenes ActA pro-
tein: a protein that enables Listeria to exploit the host’s actin
cytoskeleton for its motility during the infection process [8].
However, these ActA sequences do not ful¢ll our criteria to be
called a WH2 domain, because they lack some of the WH2
domain’s most highly conserved and functionally critical res-
idues.
2. Di¡erent classes of WH2 domain proteins
We identi¢ed 37 WH2 domain-containing proteins from the
nearly completed human, £y, worm and budding yeast ge-
nomes. Many of these proteins belonged to previously identi-
¢ed WH2 domain-containing protein families: L-thymosins,
ciboulots, WASPs (Wiskott Aldrich syndrome proteins) and
verprolins. We also identi¢ed previously unrecognized WH2
domain in Srv2/CAP (adenylyl cyclase-associated protein)
family proteins, which are known regulators of actin dynamics
(Fig. 1), and we found several novel WH2 domain-containing
proteins.
2.1. The L-thymosin family
L-Thymosins are a family of highly abundant actin mono-
mer-binding proteins. They are small proteins of 44^45 resi-
dues and are entirely composed of a single WH2 domain.
L-Thymosins are found in vertebrates, and have not been
identi¢ed in lower eukaryotes. Mammalian cells express sev-
eral L-thymosin isoforms: thymosins L4, L10 and L15. Their
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amino acid sequences are approximately 70% homologous
(Fig. 2). Thymosin L4 is the most extensively studied member
of the group. It is ubiquitously expressed [9], whereas thymo-
sins L10 and L15 appear to be expressed at certain stages of
embryonic development [10] and in cancer cells, respectively
[11,12].
Thymosin L4 forms a 1:1 complex with actin monomers
and it binds ATP-actin monomers with a 100-fold higher af-
¢nity than ADP-actin monomers. Thymosin L4 prevents actin
polymerization and its high cellular concentration (9600 WM)
allows it to maintain the large unpolymerized actin monomer
pool in the cytoplasm. Although actin bound to thymosin L4
does not polymerize, pro¢lin can compete with thymosin L4
for actin-binding and may release the actin monomer from
thymosin L4 onto the barbed end of the actin ¢lament [13].
At high concentrations (100^200 WM) thymosin L4 was re-
ported to interact with F-actin creating defects in the structure
of the polymer. Thus, thymosin L4 may have a more complex
role in actin dynamics, and this may be especially true in
motile blood cells, where its concentration can be up to 500
WM [14]. A more complex role for L-thymosins in actin dy-
namics is also supported by the observation that overexpres-
sion of one member of the family, thymosin L10, decreases the
cytoplasmic actin monomer pool in cultured NIH3T3 cells
[15].
2.2. Ciboulot-like proteins and actobindin
Recently WH2 domain-containing proteins with strong se-
quence similarity to L-thymosins were identi¢ed in D. mela-
nogaster and in C. elegans. These proteins were named cibou-
lot [16] and tetrathymosin L ([6] ; Van Troys et al.,
unpublished). Yeast and mammalian ciboulot homologues
have not been identi¢ed to date. D. melanogaster ciboulot
has a molecular weight of 14.4 kDa and is composed of three
WH2 domains, whereas the C. elegans tetrathymosin L con-
tains four WH2 domains [9]. Although Drosophila ciboulot
contains three potential actin-binding sites (WH2 domains)
it forms a 1:1 complex with actin monomers. Ciboulot shares
strong sequence similarity with L-thymosins, but the biochem-
ical properties of these two classes of WH2 domain proteins
di¡er from each other. Ciboulot binds G-actin like L-thymo-
sin, but it promotes the assembly of actin monomers at the
¢lament’s barbed end while L-thymosin inhibits actin poly-
merization [16]. Ciboulot’s activity is similar to pro¢lin’s, a
structurally unrelated actin monomer-binding protein [17],
and overexpressing pro¢lin compensates for the lack of cibou-
lot during the development of adult brain [16]. The C. elegans
tetrathymosin displays similar pro¢lin-like properties in vitro,
which most probably arise from a di¡erential, though coop-
erative activity of the WH2 repeats which are all able to bind
actin. Interestingly, one WH2 repeat functions as a pure se-
questerer whereas another preferentially interacts with F-actin
(Van Troys et al., unpublished).
Actobindin is a small actin-binding protein of Acanthamoe-
ba castellanii. It consists of two WH2 domains and binds one
or two actin molecules depending on the proteins’ concentra-
tions [18]. The heterotrimeric actobindin^actin complex is in-
competent for nucleation, self-association and elongation;
however, when actobindin dissociates from this complex, the
actin dimer can join to a pre-existing ¢lament. Thus actobin-
din can accelerate the elongation at the ends of uncapped
¢laments while blocking formation of new ¢laments [19]. Fur-
ther biochemical studies are required to determine whether
actobindin’s function is more closely related to that of cibou-
lot or the L-thymosins.
2.3. WASP, N-WASP (neural WASP) and WAVE
WASP was identi¢ed as a gene that is mutated in the he-
matopoietic cells of patients with Wiskott Aldrich syndrome.
Its overexpression caused actin clustering, suggesting a role in
actin polymerization [20]. N-WASP was initially isolated from
the brain [21] but is ubiquitously expressed and its sequence is
approximately 50% similar to WASP. WASP, N-WASP, and
their yeast homologue, Las17p, stimulate the Arp2/3 complex
to nucleate actin ¢laments [22^24].
Both WASP and N-WASP contain several di¡erent protein
domains, including a WH1/EVH1 domain, a GBD/CRIB
domain, a basic region, a proline-rich domain, a co¢lin-like
domain and an acidic region. WASP also contains one WH2
domain and N-WASP contains tandem WH2 domains (Fig. 1).
The activity and localization of WASP and N-WASP are
regulated through the N-terminal WH1/EVH1 and GBD/
CRIB domains [23,25,26], and their e¡ector domains are
the WH2 and co¢lin-like domains and the acidic region
[27]. The acidic region, together with its neighboring ele-
ments, binds the Arp2/3 complex causing it to initiate the
assembly of new ¢laments. The WH2 domain binds actin
monomers and is believed to facilitate the assembly of these
monomers into newly forming actin ¢laments [28]. A syn-
thesized WH2 domain of WASP inhibits the spontaneous
nucleation of actin ¢laments and prevents the assembly of
monomers to the ¢laments’ pointed ends but not to their
barbed ends [29].
WAVE1/Scar proteins were identi¢ed by virtue of their sim-
Fig. 1. Domain structures of WH2 motif-containing proteins. Thy-
mosin L4 is composed of a single WH2 domain. Drosophila ciboulot
has three tandem WH2 domains. Yeast verprolin and human WIP
are proline-rich proteins that contain two WH2 domains in their
N-terminal regions and a WASP-binding domain near their C-termi-
nus. The N-terminal region of N-WASP contains a WH1 domain
and a CRIB region that are important for its regulation, its two
WH2 domains and its C-terminal acidic region are essential for in-
teractions with actin and Arp2/3. Similarly, the N-terminal regions
of WAVE proteins have a regulatory role, while the WH2 domains
and acidic regions are involved in the Arp2/3-induced actin ¢lament
assembly. Srv2/CAP contains the cyclase-binding domain followed
by a proline-rich region and a WH2 domain.
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ilarity to WASP and N-WASP [30]. Mammalian WAVE1 and
WAVE3 are expressed only in brain, whereas WAVE2 is ubiq-
uitously expressed except in skeletal muscle [31]. The WAVEs
consist of an N-terminal SHD or Scar homology domain, a
basic region, a long proline-rich region, a WH2 domain, a
co¢lin-like region and a highly acidic region at the C-terminus
(Fig. 1). However, they lack the N-terminal WH1 domain and
GBD domain, and are assumed to be regulated di¡erently.
Like WASP and N-WASP, WAVE1/Scar’s acidic region acti-
vates the Arp2/3 complex, and the WH2 domain is believed to
facilitate the assembly of actin monomers to the newly formed
¢laments [32].
The WASP proteins activate the Arp2/3 complex to di¡er-
ent degrees. The strongest activator is N-WASP. The studies
with chimeric proteins revealed that neither the actin-binding
activity of the WH2 domain nor the Arp2/3 complex-binding
a⁄nity of the CA domain is related directly to a potency to
activate Arp2/3 complex. Instead, the number of WH2 do-
mains is important, the tandem WH2 domain arrangement
being the most e¡ective [33].
Fig. 2. Multiple sequence alignment of WH2 motifs found in human, worm, £y, and budding yeast proteins. Residues that are essential for ac-
tin-binding are indicated with asterisks. The position of the N-terminal K-helix is shown above the sequences. Protein names, database, and ac-
cession numbers are listed below. H. sapiens : CAP SwissProt Q01518, CAP2 SwissProt P40123, ID Q9Y544 TrEMBL AL031848, ID 095550
TrEMBL AL035288, ID 043312 TrEMBL AB007889, ID 095763 TrEMBL AC004912, ID O75128 TrEMBL AB014533, N-WASP TrEMBL
D88460, ID O43312 TrEMBL AB007889, WIP TrEMBL AF031588, ID O60794 TrEMBL AL022578, ID O75128 TrEMBL AB014533,
WAVE3 TrEMBL AB020707, ID O95559 TrEMBL AL035288, ID O95763 TrEMBL AC004912, ID Q9UDY7 TrEMBL AF134304, WASP
TrEMBL AF115549, WAVE3 TrEMBL AB026543, ID Q9Y544 TrEMBL AL031848, WAVE2 TrEMBL AB026542, ID AA64 PIR S26815,
WAVE1 EMBL D87459, thymosin L4 EMBL M17733, thymosin L10 SwissProt P13472, thymosin L15 NCBI AAH000183. S. cerevisiae : Srv2
SGD YNL138W, Las17 SGD YOR181W, Vrp1 SGD YLR337W. C. elegans : Cib F08F1.8 NCBI AAB71308.1, Vrp2 PIR T16755, Vrp1 PIR
T25220, Scar PIR T23959, CAP1 NCBI AAK85482, WASP PIR T15446. D. melanogaster : Scar NCBI AAF53042, Cib NCBI CAA21832,
Vrp1 NCBI AAF46800.1, N-WASP NCBI AAF5448.1, WASP NCBI AAF56819, CG6771 gene product NCBI AAF54641, CAP NCBI
AAF51408, SPIRE TrEMBL AF184975.
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2.4. Verprolin and WIP
Verprolin is an 817-amino acid proline-rich (22%) WH2
domain-containing protein in the yeast S. cerevisiae. Cells
containing mutant verprolins have an aberrant cytoskeleton
and defects in endocytosis, distribution of mitochondrial pro-
teins and bud-site selection [34,35]. The carboxyl-terminus of
verprolin interacts with Las17p, the yeast homologue of
WASP [36]. The WH2 domain-containing N-terminal 70 ami-
no acids of verprolin bind actin in a yeast two-hybrid assay,
but deleting these residues does not totally prevent actin-bind-
ing [35]. Our BLAST searches reveal that verprolin has a
second WH2 domain, perhaps explaining the verprolin’s
N-terminal deletant’s residual actin-binding activity (Figs. 1
and 2).
WIP (WASP-interacting protein) is a human 503-amino
acid long protein, that is homologous to yeast verprolin.
Like its yeast homologue, WIP contains two WH2 domains
and has a high proline content. WIP is a functional homo-
logue of verprolin because it suppresses the defects observed
in vvrp1 and vrp1-1 cells ; this verprolin-compensatory ability
requires its WH2 and pro¢lin-binding domains [37]. Overex-
pression of WIP in mammalian cells increases F-actin content
and induces the appearance of actin-containing projections on
the cell surface; this also requires the presence of its WH2
domain [38]. Puri¢ed WIP directly interacts with N-WASP,
G-actin and F-actin. WIP retards N-WASP/Cdc42-activated
polymerization of actin mediated by the Arp2/3 complex and
stabilizes actin ¢laments [39].
2.5. Srv2 and CAP
The yeast Srv2p/CAP was identi¢ed as a component of an
adenylyl cyclase-containing complex and as a gene required
for Ras signaling [40,41]. Srv2p is a regulator of the actin
cytoskeleton, as illustrated by the abnormal morphology
Fig. 3. An unrooted phylogenetic tree of WH2 domains. This tree was produced from the alignment in Fig. 2 by the Clustal-X software.
Circles indicate the six classes of WH2 domain-containing proteins described in this article. A bar showing 10% divergence is included.
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and actin cytoskeleton in budding yeast SRV2 knockouts.
Biochemical studies showed that Srv2p and its mammalian
homologues bind and sequester monomeric actin in vitro
[42,43]. A proline-rich region in yeast Srv2p contains a con-
sensus SH3-binding motif (PXXP), that is recognized by the
SH3 domains of several proteins in vitro and is required for
the localization of Srv2p to cortical actin patches [44]. A good
candidate for a targeting protein is Abp1, which binds the
proline-rich region of Srv2p through its SH3 domain [45].
Srv2p’s actin-binding activity maps to its C-terminal region,
but the protein motif responsible for actin monomer-binding
was not identi¢ed. Our domain searches revealed a WH2 do-
main in Srv2p’s C-terminal region (Figs. 1 and 2). This WH2
domain is highly conserved in C. elegans, D. melanogaster and
mammalian homologues of Srv2p, suggesting that this region
is important for the biological function of Srv2p/CAP.
2.6. Others
D. melanogaster p150-Spir protein contains an acidic region
followed by two WH2 domains, and it has been proposed that
it promotes actin ¢lament assembly in a fashion similar to
WASP/WAVE proteins [46]. The WH2 domain mediates
p150-Spir’s interaction with actin monomers, but its biochem-
ical activities have not been characterized. D. melanogaster
p150-Spir seems to function with actin and rho family
GTPases in patterning the Drosophila oocyte. Defects found
in spir mutants resemble those obtained with treatment with
the actin polymerization inhibitor, cytochalasin D [47].
The BLAST and SMART searches revealed several uniden-
ti¢ed proteins. Their WH2 domain sequences are most similar
to the WASPs and WIPs (Figs. 2 and 3). They contain up to
three WH2 domains and have molecular weights ranging from
40 to 150 kDa. Some of these proteins also contain ankyrin
(ANK) repeats, which are known to mediate protein^protein
interactions.
3. Structure and actin interfaces of the WH2 domain
Our knowledge of the structure and actin interfaces of the
WH2 domains is from studies on thymosin L4. The structure
of thymosin L4 has been analyzed by nuclear magnetic reso-
nance and circular dichroism spectroscopy. Under physiolog-
ical conditions, the N-terminal region (residues 5^16) forms
an K-helix, and the rest of the molecule is unstructured
[48,49]. The binding of thymosin L4 to an actin monomer
results in an increase in non-random structure of the molecule
[49]. In the preliminary model of the thymosin L4/actin mono-
mer complex, the N-terminal K-helical region and the follow-
ing loop of thymosin L4 interact with subdomain-1 of the
actin monomer, and the C-terminal half of thymosin L4 ex-
tends towards actin subdomain-2 [49]. The N-terminal helix is
relatively well conserved in all WH2 domains (Fig. 2), suggest-
ing that they all have similar K-helical structures. In contrast,
the C-terminal halves of WH2 domains are more variable and
may therefore adopt di¡erent structures in solution or in con-
tact with actin.
The actin interfaces of thymosin L4 have been mapped by
using chemically synthesized full-length thymosin L4 variants.
These studies showed that the N-terminal part has to adopt
an K-helical conformation for actin-binding, and that several
residues play key roles in this binding [50,51]. Four of the
critical actin-binding residues, Met7, Ile10, Leu18 and
Lys19, are conserved in all WH2 domains (Fig. 2), suggesting
that WH2 domains interact with actin through a similar inter-
face. Two other critical actin-binding residues in thymosin L4,
Phe13 and Lys15, are conserved only in the L-thymosin fam-
ily: these residues may account for L-thymosin’s speci¢c actin-
binding features.
It is important to note that while L-thymosins inhibit the
assembly of actin ¢laments, other WH2 domain-containing
proteins characterized to date (WASP, WIP and ciboulot)
promote the assembly of actin ¢laments at the barbed end.
Boquet et al. [16] speculated that L-thymosin-speci¢c residues,
Glu9 and Lys12, may be important for the actin monomer
sequestering function of thymosin L4. However, mutations in
these residues do not result in dramatic defects in the actin
monomer sequestering activity of thymosin L4 [50]. Interest-
ingly, in L-thymosins there is another highly conserved resi-
due, Lys15, which is not found in any other WH2 domain
proteins (Fig. 2). Biochemical experiments showed that the
replacement of this residue by alanine has a relatively small
e¡ect on actin monomer-binding, but results in a strong defect
in actin monomer sequestering activity of thymosin L4 [50].
Therefore, this residue is an attractive candidate for being
responsible for the biochemical di¡erences between L-thymo-
sins and other WH2 domain proteins. However, other studies
have demonstrated that also the C-terminal region of L-thy-
mosins is involved in actin-binding, and that functional di¡er-
ences between L-thymosin family members are speci¢ed by the
C-terminal variability [52]. It is possible that the biochemical
di¡erences between various WH2 domains result from di¡er-
ences in the N-terminal K-helix as well as in the C-terminal
variable region.
4. Evolution of WH2 domain
Three WH2 domain proteins, WASP, verprolin/WIP and
Srv2/CAP, are present from yeast to mammals, and their do-
main organizations and positions are well conserved: these
three classes were probably present in the common ancestor
of yeast and animals. Interestingly, we did not ¢nd these three
proteins in plants, and our BLAST searches from the nearly
complete Arabidopsis genome did not reveal any WH2 do-
mains. Therefore, the WH2 domain and WH2 domain pro-
teins may have evolved after the divergence of the plant lin-
eage.
Fig. 3 shows an unrooted phylogenetic tree of all known
human, £y, worm and budding yeast WH2 domains. It is
important to note that the WH2 domain is a rather small
(V35 amino acid) protein motif, so reliable phylogenetic
analysis is di⁄cult. However, WH2 domains from each of
the known WH2 domain-containing protein families form in-
dependent branches, providing support for the relevance of
this analysis. The WH2 domains of Srv2/CAP, verprolin/
WIP and WASP proteins (with three exceptions) from yeast
to mammals are in the same branches of the tree, suggesting
that a WH2 domain was present in the ancestral WASP, WIP
and Srv2 proteins before the yeast and animal lineages di-
verged (Fig. 3). L-Thymosins and ciboulot-like proteins are
not found in yeast, and they also form a separate branch in
the phylogenetic tree: these proteins either evolved in the an-
imal lineage or were lost in fungi. Ciboulot and L-thymosins
are most homologous to the WH2 domains in verprolin/WIP.
Perhaps these proteins evolved from one of verprolin’s WH2
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domains. Finally, it is important to note that although L-thy-
mosins and ciboulot are in the same branch and have highly
similar sequences, they are biochemically di¡erent [16].
5. Conclusions
The analysis presented here demonstrates that WH2 do-
main is a highly exploited and evolutionarily conserved actin
monomer-binding motif. Interestingly, di¡erent WH2 do-
mains can either promote or prevent the assembly of actin
monomers into ¢lament. In the future, it will be important
to elucidate the molecular details of WH2 domain^actin in-
teractions and to identify the structural variations responsible
for the biochemical di¡erences between various members of
this family. There are also several uncharacterized WH2 do-
main-containing proteins whose biological and biochemical
properties have to be evaluated.
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